Open AccessSildenafil in the Treatment of Raynaud’s Phenomenon Resistant to Vasodilatory Therapy
Author(s) -
Roland Fries,
K. Shariat,
H. Wilmowsky,
Michael Böhm
Publication year - 2005
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.104.523324
Subject(s) - medicine , sildenafil , vasodilation , vasodilator agents , cardiology , raynaud disease , phenomenon , physics , quantum mechanics
Vasodilatory therapy of Raynaud's phenomenon represents a difficult clinical problem because treatment often remains inefficient and may be not tolerated because of side effects.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom